1 active not recruiting, 1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Carcinoid Tumors, Intestinal: new trials by email Literature Review of Carcinoid Tumors, Intestinal trials Research Report on Carcinoid Tumors, Intestinal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen Paltusotine, Placebo - Carcinoid Syndrome, Carcinoid | Phase 3 | Active not recruiting | Crinetics Pharmaceuticals Inc. | 141 | 2025-11-19 | 2026-10-15 |
| Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome Randomized: 40 mg Paltusotine, Randomized: 80 mg Paltusotine - Carcinoid Syndrome, Carcinoid | Phase 2 | Completed | Crinetics Pharmaceuticals Inc. | 36 | 2022-04-22 | 2026-03-19 |
Carcinoid Tumor (2) · Neuroendocrine Tumors (2) · Serotonin Syndrome (2)
Adenocarcinoma (2) · Carcinoma (2) · Chemically-Induced Disorders (2) · Drug-Related Side Effects and Adverse Reactions (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2)
Crinetics Pharmaceuticals Inc. (2)
Argentina (2) · Brazil (2) · Mexico (2) · Poland (2) · United States (2) · Belgium (1) · Canada (1) · Chile (1) · Colombia (1) · France (1) · Germany (1) · Italy (1) · Peru (1) · Romania (1) · Spain (1)